Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir in Chronic Hepatitis C Genotype 1 (Prior Treatment Failure)
NCT00708500Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2008
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Aug 2008; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00708500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708500.